Oracle Investment Management Inc. lowered its position in Accelerate Diagnostics, Inc. (NASDAQ:AXDX – Free Report) by 18.3% during the 4th quarter, Holdings Channel reports. The firm owned 111,575 shares of the medical research company’s stock after selling 24,953 shares during the quarter. Accelerate Diagnostics comprises approximately 0.3% of Oracle Investment Management Inc.’s investment portfolio, making […]